Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03370848 · ClinicalTrials.gov registry record · Phase 4
Effects of Psyllium on Niacin Tolerability
A Phase 4 study of Dyslipidemias and Hyperlipidemias, sponsored by VA Greater Los Angeles Healthcare System.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT03370848 is a Phase 4 study of Dyslipidemias and Hyperlipidemias that has completed, run by VA Greater Los Angeles Healthcare System. The registered enrollment target is 26 participants, below the 232-participant average among 28 other Dyslipidemias trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03370848, a Phase 4 study of Dyslipidemias and Hyperlipidemias, has completed, sponsored by VA Greater Los Angeles Healthcare System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether psyllium is effective in reducing flushing due to niacin and also to measure the effect of niacin on cholesterol levels.
Conditions Studied
Interventions
- DRUG Aspirin
- DIETARY_SUPPLEMENT Psyllium
Study Locations (1)
California
- VA West Los Angeles Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03370848
The ClinicalTrials.gov registry entry for NCT03370848 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 232-participant average among 28 other Dyslipidemias trials with a reported enrollment target (89% lower). The listed sponsor is VA Greater Los Angeles Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Dyslipidemias appearing as the primary indexed condition, and to 2 interventions - of which Aspirin is the first listed.
NCT03370848 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03370848 about?
NCT03370848 is a clinical study titled "Effects of Psyllium on Niacin Tolerability". The purpose of this study is to determine whether psyllium is effective in reducing flushing due to niacin and also to measure the effect of niacin on cholesterol levels.
What is the current status of trial NCT03370848?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2009-03. Estimated completion is 2011-07.
What conditions does trial NCT03370848 study?
This clinical trial studies the following conditions: Dyslipidemias, Hyperlipidemias, Flushing.
What interventions are being tested in trial NCT03370848?
The interventions under investigation include: Aspirin (DRUG), Psyllium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03370848?
This trial is sponsored by VA Greater Los Angeles Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03370848 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyslipidemias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
'Ai Pono Cooking Demonstrations
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Military Health and Nutrition Examination Study
RECRUITING
-
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.